These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29628309)

  • 41. ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.
    Park UH; Kang MR; Kim EJ; Kwon YS; Hur W; Yoon SK; Song BJ; Park JH; Hwang JT; Jeong JC; Um SJ
    Oncogene; 2016 Jul; 35(28):3742-52. PubMed ID: 26640146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).
    Malissein E; Meunier E; Lajoie-Mazenc I; Médale-Giamarchi C; Dalenc F; Doisneau-Sixou SF
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2079-88. PubMed ID: 24096540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
    Liu H; Qiu J; Li N; Chen T; Cao X
    J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells.
    Magne Nde CB; Casas Gimeno G; Docanto M; Knower KC; Young MJ; Buehn J; Sayed E; Clyne CD
    J Mol Biol; 2018 May; 430(10):1531-1543. PubMed ID: 29555554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cells.
    Sun Y; Kasiappan R; Tang J; Webb PL; Quarni W; Zhang X; Bai W
    J Biol Chem; 2014 May; 289(18):12217-31. PubMed ID: 24619425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
    Kim Y; Kim H; Jang SW; Ko J
    Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
    Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
    J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
    Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
    Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
    Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
    Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
    Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
    Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
    Das N; Datta N; Chatterjee U; Ghosh MK
    Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
    Dong J; Tsai-Morris CH; Dufau ML
    J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression.
    Tan WJ; Chan JY; Thike AA; Lim JC; Md Nasir ND; Tan JS; Koh VC; Lim WK; Tan J; Ng CC; Rajasegaran V; Nagarajan S; Bay BH; Teh BT; Tan PH
    J Clin Pathol; 2016 Oct; 69(10):858-65. PubMed ID: 27056456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.